Skip to main content

Latest collections open to submissions

NEW! Racial and ethnic disparities in cancer care

Guest Edited by Shakira Grant and Gregory Vidal

Challenges and advances in brain tumor diagnosis and treatment

Guest Edited by Antonella Castellano, Mustafa Aziz Hatiboglu,  Imran Khan

Cancer therapy: KRAS targeted therapies

Guest Edited by Biswarup Saha and Hitendra Singh Solanki

Editor's Pick

Research: Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia

New Editorial: Advances in personalized radiotherapy

Research: Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study

Trial protocol: Personalised exercise rehabilitation in cancer survivorship: the percs triage and referral system study protocol

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!


Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions

Aims and Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

Testicular Cancer Prevention Month

July - Sarcoma Awareness Month

Testicular Cancer Prevention Month runs for the whole of April. We hope you will enjoy reading the following article recently published in BMC Cancer supporting the choice of an active surveillance strategy for the majority of CSI GCC patients.

New Content ItemExcellent survival in relapsed stage I testicular cancer

Become an Editorial Board Member

We are recruiting new Editorial Board Members.

Read More

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2023 Speed
    30 days submission to first editorial decision for all manuscripts (Median)
    150 days submission to accept (Median)

    2023 Usage 
    3,975 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal